New findings on adipose tissue physiology and obesity-associated inflammation status suggest that modification of the adipokine level can be relevant for the long-term prevention of obesity-associated chronic disease.
Objectives:
The scope of the present study was to investigate the effectiveness of physical exercise in reducing the systemic inflammation related to obesity in children.
Methods:
We conducted a systematic review with meta-analysis of controlled randomized trials, identified through electronic database search, which investigated the effect of physical exercise, without concomitant dietary intervention, on adiponectin, leptin, and/or other inflammatory markers in children up to age 18 years with a body mass index greater than the 95th percentile for age and sex.
Results:
Seven trials were included in the meta-analysis, with a total of 250 participants. Compared with the control group without any lifestyle modification, the physical exercise resulted in a reduction in leptin [standardized mean difference (SMD) −1.13; 95% confidence interval (95%CI): −1.89 to −0.37; I2 = 79.9%] and interleukin-6 (SMD −0.84; 95%CI: −1.45 to −0.23, I2 = 0.9%) and an increase in adiponectin plasma concentration (SMD 0.69; 95%CI: 0.02–1.35; I2 = 74.3%).
Conclusions:
These results indicate that physical exercise improved the inflammatory state in children with obesity. It is unclear whether this effect can reduce the risk of cardiovascular and metabolic disease in adulthood. Clinical trials with a uniform intervention protocol and outcome measurements are required to put our knowledge on adipose tissue biology into a clinical perspective.
Get full access to this article
View all access options for this article.
References
1.
JuonalaM, MagnussenCG, BerensonGS, et al.Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med, 2011; 365:1876–1885.
2.
LombardoFL, SpinelliA, LazzeriG, et al; OKkio alla SALUTE Group 2010. Severe obesity prevalence in 8- to 9-year-old italian children: A large population-based study. Eur J Clin Nutr, 2015; 69:603–608.
3.
KershawEE, FlierJS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab, 2004; 89:2548–2556.
4.
DengY, ScherePE. Adipokines as novel biomarkers and regulators of metabolic syndrome. Ann N Y Acad Sci, 2010; 1212:E1–E19.
5.
JaleelA, AheedB, JaleelS, et al.Association of adipokines with obesity in children and adolescents. Biomark Med, 2013; 7:731–735.
6.
AycanZ, BerberoğluM, OcalG, et al.Relationship between plasma leptin, insulin and tumor necrosis factor alpha in obese children. J Pediatr Endocrinol Metab, 2005; 18:275–284.
7.
LeeJH, ReedDR, PriceRA. Leptin resistance is associated with extreme obesity and aggregates in families. Int J Obes Relat Metab Disord, 2001; 25:1471–1473.
8.
ShehzadA, IqbalW, ShehzadO, LeeYS. Adiponectin: Regulation of its production and its role in human diseases. Hormones, 2012; 11:8–20.
9.
KwonH, PessinJE. Adipokines mediate inflammation and insulin resistance. Front Endocrinol (Lausanne), 2013; 4:71.
10.
SchoppenS, RiestraP, García-AnguitaA, et al.Leptin and adiponectin levels in pubertal children: Relationship with anthropometric variables and body composition. Clin Chem Lab Med, 2010; 48:707–711.
11.
MaachiM, PiéroniL, BruckertE, et al.Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord, 2004; 28:993–997.
12.
BastardJP, MaachiM, LagathuC, et al.Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw, 2006; 17:4–12.
13.
HanTS, LeanME. A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM Cardiovasc Dis, 2016; 5:2048004016633371.
14.
AllisonDB, ZannolliR, FaithMS, et al.Weight loss increases and fat loss decreases all-cause mortality rate: Results from two independent cohort studies. Int J Obes Relat Metab Disord, 1999; 23:603–611.
15.
HarringtonM, GibsonS, CottrellRC. A review and meta-analysis of the effect of weight loss on all-cause mortality risk. Nutr Res Rev, 2009; 22:93–108.
16.
BaillotA, RomainAJ, Boisvert-VigneaultK, et al.Effects of lifestyle interventions that include a physical activity component in class II and III obese individuals: A systematic review and meta-analysis. PLoS One, 2015; 10:e0119017.
17.
WoodcockJ, FrancoOH, OrsiniN, RobertsI. Non-vigorous physical activity and all-cause mortality: Systematic review and meta-analysis of cohort studies. Int J Epidemiol, 2011; 40:121–138.
18.
PedersenBK. Body mass index-independent effect of fitness and physical activity for all-cause mortality. Scand J Med Sci Sports, 2007; 17:196–204.
19.
MoherD, LiberatiA, TetzlaffJ, et al.Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ, 2009; 339:b2535.
20.
HigginsJPT, AltmanDG, SterneJAC, editors. Assessing risk of bias in included studies. In: HigginsJPT, GreenS,editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [Internet]. The Cochrane Collaboration; 2011. Available at: www.handbook.cochrane.org (last accessed September10, 2017).
21.
Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
22.
DerSimonianR, LairdN. Meta-analysis in clinical trials. Control Clin Trials, 1986; 7:177–188.
23.
FazelifarS, EbrahimK, SarkisianV. Effect of concurrent training and detraining on anti-inflammatory biomarker and physical fitness levels in obese children. Rev Bras Med Esporte [Internet], 2013; 19:349–54. Available at: www.scielo.br/scielo.php?script=sci_arttext&pid=S1517–86922013000500010&lng=en (last accessed September10, 2017).
24.
KimES, ImJA, KimKC, et al.Improved insulin sensitivity and adiponectin level after exercise training in obese Korean youth. Obesity (Silver Spring), 2007; 15:3023–3030.
25.
RacilG, ZouhalH, ElmontassarW, et al.Plyometric exercise combined with high-intensity interval training improves metabolic abnormalities in young obese females more so than interval training alone. Appl Physiol Nutr Metab, 2016; 41(1):103–109.
26.
VasconcellosF, SeabraA, CunhaF, et al.Health markers in obese adolescents improved by a 12-week recreational soccer program: A randomised controlled trial. J Sports Sci, 2016; 34:564–575.
27.
FazelifarS, EbrahimK, SarkisianV. Effect of exercise training and detraining on leptin levels in obese young boys. Med Sport, 2013; 66:325–337.
28.
KaracabeyK. The effect of exercise on leptin, insulin, cortisol and lipid profiles in obese children. J Int Med Res, 2009; 37:1472–1478.
29.
MonteiroPA, ChenKY, LiraFS, et al.Concurrent and aerobic exercise training promote similar benefits in body composition and metabolic profiles in obese adolescents. Lipids Health Dis, 2015; 14:153.
30.
García-HermosoA, Ceballos-CeballosRJM, Poblete-AroCE, et al.Exercise, adipokines and pediatric obesity: A meta-analyis of randomized controlled trials. Int J Obes (Lond), 2017; 41:475–482.
31.
García-HermosoA, Sánchez-LópezM, EscalanteY, et al.Exercise-based interventions and C-reactive protein in overweight and obese youths: A meta-analysis of randomized controlled trials. Pediatr Res, 2016; 79:522–527.
32.
MantovaniRM, RochaNP, MagalhãesDM, et al.Early changes in adipokines from overweight to obesity in children and adolescents. J Pediatr (Rio J), 2016; 92:624–630.
33.
GarauletM, Perex-LlamasF, FuenteT, et al.Anthropometric, computed tomography and fat cell data in an obese population: Relationship with insulin, leptin, tumor necrosis factor-alpha, sex hormone-binding globulin and sex hormones. Eur J Endocrinol, 2000; 143:657–666.
34.
AhmedML, OngKK, MorrellDJ, et al.Longitudinal study of leptin concentrations during puberty: Sex differences and relationship to changes in body composition. J Clin Endocrinol Metab, 1999; 84:899–905.
35.
Burt SolorzanoCM, McCartneyCR. Obesity and the pubertal transition in girls and boys. Reproduction, 2010; 140:399–410.
36.
GuerraB, SantanaA, FuentesT, et al.Leptin receptors in human skeletal muscle. J Appl Physiol, 2007; 102:1786–1792.
37.
BottnerA, KratzschJ, MullerG, et al.Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab, 2004; 89:4053–4061.
38.
PaltoglouG, SchoinaM, ValsamakisG, et al.Interrelations among the adipocytokines leptin and adiponectin, oxidative stress and aseptic inflammation markers in pre- and early-pubertal normal-weight and obese boys. Endocrine, 2017; 55:925–933.
39.
BouassidaA, ChamariK, ZaoualiM, et al.Review on leptin and adiponectin responses and adaptations to acute and chronic exercise. Br J Sports Med, 2010; 44:620–630.
40.
WillisLH, SlentzCA, BatemanLA, et al.Effects of aerobic and/or resistance training on body mass and fat mass in overweight or obese adults. J Appl Physiol, 2012; 113:1831–1837.
41.
BatemanLA, SlentzCA, WillisLH, et al.Comparison of aerobic versus resistance exercise training effects on metabolic syndrome (from the Studies of a Targeted Risk Reduction Intervention Through Defined Exercise - STRRIDE-AT/RT). Am J Cardiol, 2011; 108:838–844.
42.
ZimmerlinL, DonnenbergVS, RubinJP, et al.Mesenchymal markers on human adipose stem/progenitor cells. Cytometry, 2013; 83A:134–140.
43.
EderK, BaffyN, FalusA, et al.The major inflammatory mediator interleukin-6 and obesity. Inflamm Res, 2009; 58:727–736.
44.
PetersenAM, PedersenBK. The anti-inflammatory effect of exercise. J Appl Physiol, 2005; 98:1154–1162.
45.
FlynnMA, McNeilDA, MaloffB, et al.Reducing obesity and related chronic disease risk in children and youth: A synthesis of evidence with “best practice” recommendations. Obes Rev, 2006; 7(Suppl 1):7–66.
46.
MyersMGJr, LeibelRL, SeeleyRJ, SchwartzMW. Obesity and leptin resistance: Distinguishing cause from effect. Trends Endocrinol Metab, 2010; 21:643–651.
47.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 2002; 106:3143–3421.
48.
FarooqA, SorathiaS, ShaharyarS, et al.Metabolically healthy obesity and the Fit/Fat phenotype: Associations with mortality, subclinical cardiovascular disease and approach to treatment. J Metabolic Synd, 2015; 4:2.
49.
RobersonLL, AneniEC, MaziakW. Beyond BMI: The “Metabolically healthy obese” phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality—A systematic review. BMC Public Health, 2014; 14:14.
50.
KramerCK, ZinmanB, RetnakaranR. Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med, 2013; 159:758–769.
51.
BarryV, BaruthM, BeetsMW, et al.Fitness vs. fatness on all-cause mortality: A meta-analysis. Prog Cardiovasc Dis, 2014; 56:382–390.
52.
HarrisRB. Direct and indirect effects of leptin on adipocyte metabolism. Biochim Biophys Acta, 2014; 1842:414–423.
53.
MullerG, ErtlJ, GerlM, et al.Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem, 1997; 272:10585–10593.
54.
WangTN, ChangWT, ChiuYW, et al.Relationships between changes in leptin and insulin resistance levels in obese individuals following weight loss. Kaohsiung J Med Sci, 2013; 29:436–443.
55.
SuccurroE, MariniMA, FrontoniS, et al.Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. Obesity (Silver Spring), 2008; 16:1881–1886.
56.
AmatoMC, GuarnottaV, GiordanoC. Body composition assessment for the definition of cardiometabolic risk. J Endocrinol Invest, 2013; 36:537–543.
57.
RubinDA, McMurrayRG, HarrellJS, et al.Do surrogate markers for adiposity relate to cytokines in adolescents?. J Investig Med, 2008; 56:786–792.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
